Get started
Author

Carrianne Ludwig

Observed name: C. Ludwig
OpenAlex ID: A5023745209
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
2021 · Aaron S. Mansfield, David S. Hong, et al. · npj Precision Oncology · 80
PDF
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC
2021 · Christine L. Hann, Timothy F. Burns, et al. · Journal of Thoracic Oncology · 42
PDF
O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
2005 · G. Blumenschein, C. Ludwig, et al. · Lung Cancer · 24
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing, advanced solid tumors.
2020 · Aaron Scott Mansfield, David S. Hong, et al. · Journal of Clinical Oncology · 14
A First-in-Human Phase 1 Study of ABBV-525, a Small-Molecule MALT1 Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
2023 · Andrew L. Sochacki, Jan A. Burger, et al. · Blood · 6
A phase I study evaluating rovalpituzumab tesirine (ROVA-T) in frontline treatment of patients (pts) with extensive stage small cell lung cancer (ES-SCLC)
2019 · C. Hann, T. Burns, et al. · Annals of Oncology · 5
Gemcitabine (GEM) and capecitabine (CAP) for advanced pancreatic cancer. A phase I/II trial
2001 · V. Hess, M. Bomer, et al. · European Journal of Cancer · 3
136MO: Predictors of multidisciplinary tumor board adherence in stage III non-small cell lung cancer patients from a large multicenter study
2025 · M. Joerger, K-L. Koster, et al. · Journal of Thoracic Oncology
PDF
Works count: 8
Citation count: 174
H-index: 5
I10-index: 4
Year
Topic
Type